An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

You may be eligible if

• Continuous medical and pharmacy benefit coverage for at minimum 6 months prior to and including the estimated LMP
• Diagnosis code indicative of AD in the period from up to 1 year prior to the estimated LMP through the end of the pregnancy